Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine in High-Risk Occupational Population: a randomized, parallel, controlled clinical trial
Yongliang Feng, Jing Chen, Tian Yao, Yue Chang, Xiaoqing Li, Rongqin Xing, Hong Li, Ruixue Xie, Xiaohong Zhang, Zhiyun Wei, Shengcai Mu, Ling Liu, Lizhong Feng, Suping Wang
doi: https://doi.org/10.1101/2021.08.06.21261696
Yongliang Feng
aSchool of Public Health, Shanxi Medical University, Taiyuan, China
bCenter of Clinical Epidemiology and Evidence Based Medicine, Shanxi Medical University, Taiyuan, China
Jing Chen
cShanxi Provincial Center for Disease Control and Prevention, Taiyuan, China
dShanxi Provincial Key Laboratory for major infectious disease response
Tian Yao
aSchool of Public Health, Shanxi Medical University, Taiyuan, China
bCenter of Clinical Epidemiology and Evidence Based Medicine, Shanxi Medical University, Taiyuan, China
Yue Chang
aSchool of Public Health, Shanxi Medical University, Taiyuan, China
bCenter of Clinical Epidemiology and Evidence Based Medicine, Shanxi Medical University, Taiyuan, China
Xiaoqing Li
cShanxi Provincial Center for Disease Control and Prevention, Taiyuan, China
dShanxi Provincial Key Laboratory for major infectious disease response
Rongqin Xing
eOutpatient Department of Shanxi Aviation Industry Group Co. LTD
Hong Li
cShanxi Provincial Center for Disease Control and Prevention, Taiyuan, China
dShanxi Provincial Key Laboratory for major infectious disease response
Ruixue Xie
aSchool of Public Health, Shanxi Medical University, Taiyuan, China
bCenter of Clinical Epidemiology and Evidence Based Medicine, Shanxi Medical University, Taiyuan, China
Xiaohong Zhang
cShanxi Provincial Center for Disease Control and Prevention, Taiyuan, China
dShanxi Provincial Key Laboratory for major infectious disease response
Zhiyun Wei
cShanxi Provincial Center for Disease Control and Prevention, Taiyuan, China
dShanxi Provincial Key Laboratory for major infectious disease response
Shengcai Mu
cShanxi Provincial Center for Disease Control and Prevention, Taiyuan, China
dShanxi Provincial Key Laboratory for major infectious disease response
Ling Liu
cShanxi Provincial Center for Disease Control and Prevention, Taiyuan, China
dShanxi Provincial Key Laboratory for major infectious disease response
Lizhong Feng
cShanxi Provincial Center for Disease Control and Prevention, Taiyuan, China
dShanxi Provincial Key Laboratory for major infectious disease response
Suping Wang
aSchool of Public Health, Shanxi Medical University, Taiyuan, China
bCenter of Clinical Epidemiology and Evidence Based Medicine, Shanxi Medical University, Taiyuan, China
Data Availability
The full study protocol and the datasets, which includes all data fields reported in this study, are available, following manuscript publication, upon request from the corresponding author (Professor Suping Wang, supingwang{at}sxmu.edu.cn), following the provision of ethics approval.
Posted August 09, 2021.
Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine in High-Risk Occupational Population: a randomized, parallel, controlled clinical trial
Yongliang Feng, Jing Chen, Tian Yao, Yue Chang, Xiaoqing Li, Rongqin Xing, Hong Li, Ruixue Xie, Xiaohong Zhang, Zhiyun Wei, Shengcai Mu, Ling Liu, Lizhong Feng, Suping Wang
medRxiv 2021.08.06.21261696; doi: https://doi.org/10.1101/2021.08.06.21261696
Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine in High-Risk Occupational Population: a randomized, parallel, controlled clinical trial
Yongliang Feng, Jing Chen, Tian Yao, Yue Chang, Xiaoqing Li, Rongqin Xing, Hong Li, Ruixue Xie, Xiaohong Zhang, Zhiyun Wei, Shengcai Mu, Ling Liu, Lizhong Feng, Suping Wang
medRxiv 2021.08.06.21261696; doi: https://doi.org/10.1101/2021.08.06.21261696
Subject Area
Subject Areas
- Addiction Medicine (369)
- Allergy and Immunology (689)
- Anesthesia (184)
- Cardiovascular Medicine (2748)
- Dermatology (235)
- Emergency Medicine (414)
- Epidemiology (12398)
- Forensic Medicine (10)
- Gastroenterology (784)
- Genetic and Genomic Medicine (4259)
- Geriatric Medicine (396)
- Health Economics (699)
- Health Informatics (2756)
- Health Policy (1018)
- Hematology (369)
- HIV/AIDS (879)
- Medical Education (404)
- Medical Ethics (112)
- Nephrology (453)
- Neurology (4036)
- Nursing (216)
- Nutrition (598)
- Oncology (2126)
- Ophthalmology (604)
- Orthopedics (251)
- Otolaryngology (312)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (478)
- Pediatrics (1148)
- Primary Care Research (468)
- Public and Global Health (6652)
- Radiology and Imaging (1446)
- Respiratory Medicine (886)
- Rheumatology (421)
- Sports Medicine (353)
- Surgery (464)
- Toxicology (57)
- Transplantation (192)
- Urology (171)